Ornithine Transcarbamylase Deficiency, an X-linked disorder, is the most common cause of inherited urea cycle disorders. Approx. 90 mutations that produce reduced levels of ornithine transcarbamylase (OTCase) activity have been identified in patients [Tuchman (1993) 
INTRODUCTION
The most common disorder of inherited hyperammonaemia is Xlinked Ornithine Transcarbamylase Deficiency resulting from defects in ornithine transcarbamylase (ornithine transcarbamylase, OTCase, EC 2.1.3.3), an enzyme of the urea cycle that catalyses the formation of citrulline and inorganic phosphate from carbamoyl phosphate and -ornithine [1] . Many different mutations in the human ornithine transcarbamylase gene result in dysfunctional enzymes that give rise to hyperammonaemia and subsequent brain damage. Severe mutations in males may cause death in the newborn period while the symptoms of males with milder mutations may not become apparent until later in life. Approx. 90 mutations in the ornithine transcarbamylase gene that produce reduced OTCase activity have been identified [2, 3] .
Aspartate transcarbamylases (ATCase, EC 2.1.3.2) and OTCases from various species appear to form a family of proteins in which the three-dimensional structure is conserved despite variability in sequence and function [4] [5] [6] [7] . Human OTCase shares 27 % amino acid sequence identity and 46 % similarity with the catalytic subunit of Escherichia coli ATCase, for which the three-dimensional structure in the holoenzyme has analogous to a similar loop (the 240's loop, a flexible loop of the catalytic chain of Escherichia coli aspartate transcarbamylase, comprised of residues 230-250) of ATCase. Human wild-type OTCase and the R277W mutant have been cloned and overexpressed in E. coli and a rapid and efficient purification method utilizing the bisubstrate analogue, N δ -(phosphonacetyl)--ornithine, has been developed and used to purify both proteins. Gel chromatography indicates both are trimeric. The pH dependence of the kinetic parameters of the wild-type enzyme is similar to that of E. coli OTCase [Kuo, Herzberg and Lipscomb (1985) Biochemistry 24, 4754-4761], suggesting that its catalytic mechanism is similar, although its maximal activity is approx. 10-fold less. Compared with the wild-type, the R277W mutant has nearly 70-fold lower affinity for -ornithine, shows no substrate inhibition, and its thermal stability is reduced by 5 mC. Its reduced affinity for -ornithine, which in turn results in lower activity at physiological concentrations of ornithine, as well as its reduced stability, may contribute to the clinical effects that it produces.
been determined by X-ray crystallography [PDB : 8AT1] [8] . We previously used the ATCase structure to develop a homologybased model of human OTCase [9] that is in good agreement with the recently reported crystal structure of Pseudomonas aeruginosa OTCase (Figure 1 ) [5] . In addition, we mapped the mis-sense mutations that result in clinical symptoms on the model (Figure 2 ). Many of these alterations are located at the active site or in the interior of the protein, where they would be expected to interfere with catalysis, folding or stability. Some, however, are located in regions of the molecule that do not have an obvious functional role. Hence, further structural and biochemical studies are required to understand how these mutations give rise to dysfunctional OTCase enzymes and Ornithine Transcarbamylase Deficiency.
One of the few recurrent mutations occurs in exon 8 of the OTC gene, where the mutation of CGG to TGG produces the R277W mutant. This mutation generally does not produce any symptoms until adulthood, when a severe clinical episode may unexpectedly occur. Although Arg-277 is well conserved across species, it is located in the homology model in a loop remote from the active site (Figures 1 and 2 ). This loop is homologous to a functionally important region of E. coli ATCase, the 240's loop (a flexible loop of the catalytic chain of E. coli ATCase,
Figure 1 Superposition of the homology model of human OTCase (light grey trace) and the crystal structure of P. aeruginosa OTCase (thin dark-grey trace)
The loop inserted in bacterial OTCases is shown as a thick dark-grey trace ; the corresponding sequence in human OTCase is shown as a thick light-grey trace. The r.m.s. difference between backbone atoms is 2.9 AH . The Figure was generated with the program RasMol [37] . The three-fold axis lies on the left side of the molecule, approx. vertical in the plane of the page. Interchain interfaces are formed on the left, and in front of the subunit displayed. The locations of mutations that give rise to neonatal ($) or late onset (#) OTC deficiency are shown. Arg-277 is indicated by the arrow.
comprised of residues 230-250), which forms an intersubunit contact in the T state and swings in towards the active site in the R state to bring the two domains of the catalytic chain closer together [10] . It is also adjacent to an extended loop found in E. coli OTCases and all sequenced catabolic Pseudomonas and Neisseria OTCases (Figure 1) .
We have cloned, overexpressed, purified to homogeneity and studied the kinetic parameters of mature human OTCase over a range of pH and compared them with those of E. coli OTCase, with which human OTCase shares 59 % sequence identity. We have also cloned and purified to homogeneity the recombinant R277W mutant and compared its kinetic parameters and thermal stability with those of the wild-type enzyme. The results indicate that the clinical effects of R277W may depend upon a combination of reduced affinity for -ornithine, which in turn results in reduced catalytic activity at physiological concentrations of ornithine, as well as reduced stability.
EXPERIMENTAL

Construction of OTCase expression vector (pETOTCII)
Plasmid pSPROTC4, with the mature human OTC cDNA minus the first four codons beyond the leader sequence (codon 37-355) inserted in pSP64, was obtained from Dr. Arthur Horwich at Yale University. An EcoRI-SacI fragment from pSPROTC4 containing the cDNA was cloned into a T7-lac expression vector (pET21aj, Novagen) forming the pETOTCI plasmid. In addition to lacking the codons for the first four amino acids of mature OTCase, the new construct also contains an additional T7-Tag sequence downstream to the promoter. To remove the T7-Tag sequence and incorporate the missing codons, a short fragment overlapping the promoter and the cDNA (150 bp) was amplified by PCR. The forward primer contained the first four codons and the cDNA sequence with an NdeI site at its 5h end while the reverse primer contained an SauI site. The expression vector and PCR fragment were digested with NdeI and SauI and the digested fragment was ligated into the vector creating a new plasmid (pETOTCII) containing the entire sequence of the mature OTCase with a methionine codon (ATG) at its 5h-end downstream to a T7 promoter and a lac operator. The incorporated fragment was sequenced to exclude PCR errors.
Construction of R277W plasmid (pETOTCIV)
An expression vector for the R277W (CGG to TGG) human OTCase mutant was constructed by PCR site-directed mutagenesis as described below. Sense and anti-sense overlapping 19-mer oligonucleotides containing the mutation at the 10th position were synthesized. These primers and two additional flanking primers were used to amplify two fragments of the ornithine transcarbamylase gene (OTC) by PCR containing KpnI and SpeI restriction sites respectively. The two fragments were combined in one PCR reaction to amplify a common DNA fragment containing the R277W mutation and the KpnI and SpeI sites at the 5h and 3h ends respectively. This fragment ' cassette ' was cloned into pETOTCII. The cloned fragment was sequenced to verify the mutation and to exclude PCR errors.
GroES and GroEL plasmid (pGroESL)
Plasmid pGroESL, derived from pACYC184 expressing E. coli chaperonin genes GroES and GroEL, was obtained from Dr. Ian Krause, University of Colorado.
Synthesis of N δ -(phosphonacetyl)-L-ornithine (PALO)
PALO, a compound first described by Mori et al. [11] , was synthesized in 23 % overall yield in four steps starting from N α -(benzyloxycarbonyl)-N δ -(t-butoxycarbonyl)--ornithine, essentially as described by Alewood et al. [12] . Catalytic hydrogenation for final deprotection required analytical-grade glacial acetic acid and fresh 10 % palladium on charcoal catalyst ; yields were best (nearly quantitative) on a scale of 1 g or less. A key cointermediate, dibenzylphosphonoacetic acid, was prepared as outlined by Koppel and Kinnick [13] . Dibenzyl phosphite was deprotonated with n-butyl-lithium in dry tetrahydrofuran (69 % yield), then methylated at phosphorus, again treated with nbutyl-lithium in dry tetrahydrofuran and the resultant lithium salt was quenched by adding the cold ( k50 mC) solution under vigorous stirring to finely powdered dry ice (51 % yield after extractive workup). NMR supported the structures of all intermediates as well as the final product, melting points agreed with the literature, and C ") reversed-phase HPLC eluted with 0.1 % aqueous trifluoroacetic acid\acetonitrile gradients was used to verify purities which were 98 %.
Preparation of PALO affinity column
Dry epoxy-activated Sepharose 6B (2.5 g ; Pharmacia), washed with 1 litre of distilled water on a sintered glass filter, was reacted with 80 µmol of PALO in 25 ml of 0.1 M NaOH at 37 mC overnight in a shaker\incubator. Unbound PALO was removed by washing with 1 litre of 0.1 M NaOH, and the remaining reactive sites on the resin were blocked by incubating overnight in 1 M ethanolamine, pH 8.0, at 37 mC. The matrix was poured into a 1.5 cm diameter column, thoroughly washed with a buffer containing 20 mM Tris acetate\0.5 M KCl\2 mM EDTA, pH 7.4, and equilibrated with 20 mM Tris acetate\0.25 M KCl\2 mM EDTA, pH 7.4. The capacity of a 20 ml column exceeds 17 mg.
Protein purification
Log phase cultures of E. coli HMS174 in LB broth were transformed with pETOTCII or pETOTCIIjpGroESL, in the presence of 100 µg\ml ampicillin or 100 µg\ml ampicillin j35 µg\ml chloramphenicol respectively and were incubated overnight at 37 mC. A 10 ml aliquot was used to inoculate 1 litre of culture which was grown at 25 mC until an A '!! of 0.4-0.8 was reached. After induction overnight with 0.01 mM isopropyl-β--thiogalactoside (IPTG), the cells were harvested by centrifugation, resuspended in 10 ml of 20 mM Tris acetate\100 mM NaCl\2 mM EDTA\100 µM PMSF, pH 7.4 per gram of cells at 4 mC, and disrupted by sonication on ice for 15 min. The lysate was centrifuged for 10 min at 4 mC and 18 000 g (r av. 8.26 cm) and the supernatant was incubated with 2 mg of DNaseI, 2 mg of RNaseA and 5 mM MgCl # for 30 min at room temperature. The protein that precipitated between 1.6 and 3.6 M (NH % ) # SO % was collected by centrifugation, dissolved in a column buffer consisting of 20 mM Tris acetate\250 mM KCl\2 mM EDTA, pH 7.4 (3 ml\g of precipitate), and dialysed overnight against the same buffer. It was then loaded onto the PALO column, pre-equilibrated with the buffer, and the column was continuously washed until all unbound protein was eluted. OTCase was eluted with 10 mM carbamoyl phosphate in column buffer. The column was reconditioned with 3 vol. of column buffer containing 2 M KCl and re-equilibrated with column buffer. Fractions containing OTCase activity were pooled, and stored in 50 % v\v glycerol at k20 mC. Protein concentrations were determined with a dye-binding protein assay (Bio-Rad) using bovine serum albumin as a standard.
Purification of the R277W mutant was performed as outlined above, except that the concentration of KCl in the column buffer was decreased to 200 mM.
Analytical gel chromatography
The hydrodynamic radius of wild-type and R277W OTCase was determined with a calibrated 10 mmi150 mm Sephacryl S-300 (Pharmacia) column in 20 mM Tris acetate\200 mM KCl\2 mM EDTA, pH 7.4. Partition coefficients (σ) for a set of proteins with known Stokes' radii, wild-type OTCase and the R277W mutant were determined using Blue Dextran and glycine for the void and included markers [14] . Stokes' radii for wild-type and R277W OTCase were determined from a plot of σ versus log(Stokes' radius). Protein concentration ranged between 0.1 and 0.6 mg\ml.
Enzyme assays
OTCase activity was measured with the colorimetric assay of Pastra-Landis et al. [15] , which detects the formation of -citrulline. Unless otherwise indicated, the assay buffer was 50 mM Tris acetate\2 mM EDTA, pH 8.3. Standard curves for -citrulline were generated in each experiment as this assay is sensitive to ambient conditions [15, 16] . One unit of enzyme catalyses the formation of 1 µmol\min of -citrulline at 25 mC.
RESULTS
Expression and purification
Although approx. one-quarter of the cellular protein synthesized following induction in cells transformed with pETOTCII was OTCase, approx. one-half of it was sequestered in inclusion bodies. Soluble OTCase was maximized by optimizing IPTG concentrations and the duration and temperature of incubation. Growth in the presence of betaine or sucrose, which has increased yields in other expression systems, was not effective. Attempts to recover active OTCase from the inclusion bodies through the use of detergents and\or guanidine hydrochloride or urea, followed by overnight dialysis during which the denaturant was incrementally diluted, were unsuccessful. Although the OTCase in inclusion bodies could be solubilized by hexadecyltrimethyl ammonium bromide, the protein was inactive. Greatly increasing the renaturation time ( 45 h), as described by Marshall and Cohen [17] and Murakami et al. [18] for bovine and rat OTCase respectively, resulted in enzyme with approx. 20 % of the specific activity of the soluble protein purified by affinity chromatography. By comparison, chaperonin-mediated renaturation results in an 80 % recovery of activity after a 10 min incubation [19] . Attempts to purify OTCase by ion exchange chromatography on DEAE-Sephadex resulted in large losses in activity, as reported by Kalousek et al. [20] , although losses were reduced by using a DEAE fast-flow column, and decreasing the pH to 7 to prevent adsorption of OTCase to the matrix. (NH % ) # SO % precipitation and affinity chromatography on a PALO affinity column proved more efficient and resulted in high yields. SDS protein electrophoretic gels of samples from various stages of the purification are shown in Figure 3 . Co-expression of OTCase with GroES and GroEL allowed up to 90 % of the active protein to be recovered. The efficiency of the PALO affinity column was increased approx. 2.4-fold by incorporating a step in which nucleic acids were digested and removed by dialysis before application of the sample to the column. Dithiothreitol and β-mercaptoethanol were not used in the purification, since they inactivate the enzyme.
The overall yield of active OTCase was 90 %, with a specific activity of 40.2 µmol:mg −" :min −" ; 17 mg of pure protein was obtained from 1 litre of culture. While the host strain of E. coli has an intact copy of the argI gene, it is induced only when arginine is depleted, and control experiments indicated that
Figure 4 Determination of hydrodynamic radius
Calculated Stokes' radii for wild-type ( ) and R277W OTCase (#) and the catalytic trimer of E. coli ATCase (=) are shown. Proteins used for calibration ($) were cytochrome c, myoglobin, ovalbumin, bovine serum albumin, aldolase, catalase and ferritin.
0.8 % of the OTCase activity obtained was due to contamination by the bacterial enzyme (results not shown). Purified OTCase can be stored in 20 mM Tris acetate\2 mM EDTA, pH 7.4 with 50 % glycerol at k20 mC without loss of activity for several months.
A similar procedure was used to purify the R277W mutant, except that the concentration of KCl in the buffer for the PALO column was reduced from 250 to 200 mM to increase specific binding while still minimizing binding of other molecules. Pure protein (10 mg) was obtained from 1 litre of culture. Yield of this mutant was significantly lower at every step in the purification, so that the final yield was only 25 %.
Analytical gel chromatography
The Stokes' radius of purified wild-type and R277W OTCase are 37.0p1.1 A H and 37.8p1. 
Inhibitors and activators
The activity of OTCase is sensitive to a variety of agents. Like E. coli OTCase [21] , human OTCase is inactivated by Zn(II), although at lower (micromolar) concentrations (results not shown). Micromolar dithiothreitol and millimolar β-mercaptoethanol also inhibit human OTCase (results not shown). Enzyme activity increases with ionic strength, up to I l 0.1 M. This ionic strength effect accounts in part for the 4-6-fold increase in activity, relative to 50 mM Tris acetate, pH 8.3, observed in buffers that have high ionic strengths, such as the tripartite buffer used here in the pH studies or the borate buffer used in the thermal stability experiments.
Enzyme kinetics
Titration curves for -ornithine and carbamoyl phosphate at pH 8.3 for both wild-type and R277W OTCase are shown in 
Khj[S]
nH (1) where
Curves showing substrate inhibition were fit to an equation describing cooperative substrate binding and partial non-competitive substrate inhibition :
where K i is the dissociation constant for inhibitory substrate binding and V i is the limiting velocity at maximal substrate inhibition [16] . The non-linear least-squares program NONLIN [38] where pK a1 , pK a2 , and pK a3 are 1.7, 8.7 and 10.8 [39] and are used to calculate K m values for the zwitterionic forms of L-ornithine (panel B). Panel D : k cat zwitterion /K m calculated from panels B and C. The buffer was 51 mM 2-(N-morphlino)ethanesulphonic acid, 1 mM N-ethylmorpholine and 51 mM diethanolamine. Figure 5 . Wild-type OTCase shows pronounced substrate inhibition with -ornithine, while R277W does not. There is also slight substrate inhibition of the wild-type enzyme, but not of the R277W mutant, by carbamoyl phosphate. Apparent K m values for the wild-type enzyme (0.05p0.0.01 mM for carbamoyl phosphate and 0.11p0.02 mM for ornithine) were similar to those seen for other OTCases [20, [22] [23] [24] [25] [26] . The R277W mutation reduces affinity for -ornithine by nearly 70-fold while decreasing affinity for carbamoyl phosphate only three-fold. Although the fitted value of V max for R277W is slightly larger than for the wild-type enzyme (84.3p3.7 µmol\min per mg versus 62.5p3.4 µmol\min per mg), the greatly reduced affinity of the mutant for ornithine results in the activity of the mutant being substantially lower than the wild-type enzyme at physiological concentrations (see inset to Figure 5 ).
The gel chromatography results suggest that the reduced affinity for -ornithine of R277W is not a result of a change in the state of association of the protein. Figure 6 shows the pH dependence of the apparent kinetic parameters for -ornithine, determined in a tripartite buffer designed to maintain constant ionic strength over the pH range
pH dependence
Figure 7 Thermal stability of wild-type () and R277W (#) OTCase
Enzyme diluted to 0.045 mg/ml in 50 mM borate/50 mM KCl/2 mM EDTA, pH 8.3 was incubated at the indicated temperatures for 10 min, then quickly chilled on ice and assayed within 15 min. The solid lines through the data were calculated assuming a two-state transition from a fully active to a fully inactive species of the form :
where T m is the temperature at the midpoint of the transition, and k is a fitting constant. The temperatures at which 50 % of the activity of the wild-type and mutant protein is lost are 56p1 mC and 51.5p1 mC respectively. [27] . The apparent dependence of k cat on pH is bell-shaped with a maximum at around pH 8 ; however, OTCase gradually loses activity when incubated above pH 8.5 or below pH 6.5. The apparent K m shows little variation over pH 7.5-10, but increases sharply with decreasing pH below pH 7.0.
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This pH dependence is similar to that reported for crude homogenates of human liver and purified E. coli and bovine OTCase and has been interpreted as indicating that -ornithine binds as a zwitterion, with its side chain uncharged [1, 28, 29] . The pH dependence of the calculated K m values for the zwitterion is the opposite of that for the apparent K m values, remaining constant over the pH range 6-8.5 and increasing at high pH (Figure 6b) . These values agree closely with those reported for E. coli OTCase [28] . Figure 7 compares the thermal stability of wild-type OTCase and R277W as monitored by enzymic activity. The mutation reduces the temperature at which 50 % of the enzyme activity is lost under these conditions by approx. 5 mC, from 56p1 mC to 51.5p1 mC.
Thermal stability
DISCUSSION
Ornithine Transcarbamylase Deficiency has been well studied in terms of its clinical severity, the range of enzyme deficiency and the location of mutations in the OTC gene of affected families. However, biochemical analyses of wild-type and mutant human enzymes are sparse by comparison with OTCases from E. coli and other organisms that can be obtained more readily. Extensive kinetic analysis has been performed on bovine OTCase [17, 29, 30] . Use of the efficient overexpression system and purification procedure for recombinant human OTCase described here will enable detailed investigations of the molecular basis of ornithine transcarbamylase deficiency. Clinically important mutations can be created readily and expressed in E. coli for further characterization. The specificity of the PALO affinity column allows purification with yields of 90 % for wild-type, and can be used to purify mutants such as R277W that are able to bind one or both substrates.
Although the crystal structure of human OTCase is not yet known, the crystal structures of E. coli ATCase and P. aeruginosa OTCase provide useful insights, since the OTCases and ATCases of various species form a family of proteins in which threedimensional structure is highly conserved [4] [5] [6] [7] 9, 31] [4] .
Eight of the 12 residues at the active site of E. coli ATCase are conserved in human OTCase. Although residues involved in binding ornithine have not been well characterized, Asp-263, Ser-267, Met-268, Gly-269, His-302, Cys-303, Leu-304, and Pro-305 are highly conserved in all OTCase sequences and align with residues involved in aspartate binding in ATCase and hence are likely to be implicated in binding ornithine. The aspartate in P. aeruginosa that is equivalent to Asp-263 in the human enzyme has been postulated to bind the amino group of ornithine [5] . SThioethylamine modification of OTCase has shown the existence of a methionine that affects binding of norvaline, but not of carbamoyl phosphate [30] . The invariance of Met-268 in all OTCases, and its location in the ornithine domain of the homology model and crystal structure make it a possible candidate.
The similarity of the kinetic parameters of E. coli, bovine and human OTCase, including their pH dependence, suggests that their active sites are structurally very similar and it is likely that human OTCase, like the E. coli and bovine enzymes, binds the ornithine zwitterion with its side chain uncharged [1, 28, 29] .
Despite the similarities, there are functional and structural differences between the human and bacterial enzymes. Values of V max for human OTCase are approx. 10-fold lower than those reported for E. coli OTCase and human OTCase appears to be inactivated by Zn(II) at concentrations approx. 100-fold lower than E. coli OTCase. In addition to many specific sequence differences, some bacterial enzymes, including the E. coli and the catabolic P. aeruginosa OTCases, also have an insertion of approx. 19 amino acids in the vicinity of residues 306-307 of the human enzyme, in a loop that extends away from the putative ornithine binding site formed by residues 301-305 (Figure 1 ). Given these differences, studies of the human enzyme are important to better understand the function of this region of the protein.
In the homology-based model for human OTCase, Arg-277 is positioned in a loop remote from the active site (Figure 2) , raising the question of how a substitution of this residue gives rise to defective enzyme function, albeit generally not clinically apparent until after the newborn period and with effects less severe than those of many other mutations. The effect of the R277W mutation in human OTCase is similar to the W243I mutation in the same region of the molecule in E. coli OTCase [32] ; both increase the apparent K m for -ornithine with little change in the affinity for carbamoyl phosphate. Our value for the K m of R277W for -ornithine is similar to that obtained with a crude preparation of patient liver [33] under slightly different assay conditions [27] . The modest decreases in affinity and stability are consistent with the nature of the clinical effects of this mutation. Although the R277W mutant can catalyse the formation of citrulline at rates greater than that of the wild-type given sufficiently high concentrations of ornithine, estimates of the ornithine concentration in the mitochondrial matrix range from 0.3 mM to 1 mM [34, 35] . At these concentrations, the velocity of R277W is 12 to 24 % of wild-type ( Figure 5, inset) .
The location of the mutation in the homology model suggests a structural basis for its effects on the catalytic properties of the enzyme. The loop in which Arg-277 is located is analogous to the 240's loop of E. coli ATCase. This loop plays a critical role in the catalytic mechanism of ATCase : in the T state, it functions as the contact between the two catalytic subunits, while in the R state, it swings towards the active site to close the two domains of the catalytic chain around the substrates [36] . While the intersubunit contact is not present in the catalytic subunit of ATCase or in OTCase, domain closure would be expected still to be an essential part of the catalytic mechanism. Interestingly, the long insertion in bacterial OTCases forms a loop adjacent to the 240's loop analogue, and may also constrain motion of this loop. In P. aeruginosa OTCase, the Arg-277 homologue is fully visible on the surface of the molecule, but with only 30 % of the solvent accessibility of a fully exposed arginine. Although the mutation to a more hydrophobic residue may also affect the conformation of this region, the Arg-277 homologue is in close contact with a conserved aspartate ). This aspartate is approx. 98 % buried, suggesting that the altered pH dependence reported by Hata et al. for R277W [33] may be due to greater difficulty in deprotonating this buried aspartate in the absence of Arg-277. The human R277W mutant has a similar pH dependence.
The sheer number of OTC mutations that have been identified clinically is not only of clinical relevance but also of biochemical importance since many of the changes are at sites with no apparent functional role. These mutations warrant further investigation. The complex linkages between folding, assembly and catalytic activity that result from the trimeric structure of OTCase, in which the active site is formed by both interdomain and interchain interactions, may be in part the reason why mutations of OTCase are the most commonly detected inheritable urea-cycle disorders. Fully understanding how these mutations give rise to clinical symptoms will require a combination of experiments in itro of the type performed here, experiments with crude homogenates (such as have already been carried out with the R277W mutant to determine that purification has not altered the enzymological properties of the enzyme), as well as analyses in i o. Careful studies of structure-function relationships in the purified enzyme are an essential part of this process.
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